These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7858614)

  • 1. [Biological markers of osteoarthritis].
    Thonar EJ; Manicourt DH
    Rev Rhum Ed Fr; 1994 Nov; 61(9 Pt 2):99S-102S. PubMed ID: 7858614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body fluid markers of cartilage changes in osteoarthritis.
    Thonar EJ; Shinmei M; Lohmander LS
    Rheum Dis Clin North Am; 1993 Aug; 19(3):635-57. PubMed ID: 8210579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of a novel matrix protein with the degree of cartilage degradation.
    Schmidt-Rohlfing B; Schneider U; Thomsen M; Bosserhoff AK
    Rheumatol Int; 2002 Aug; 22(4):165-9. PubMed ID: 12172957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix proteins: potentials as body fluid markers of changes in the metabolism of cartilage and bone in arthritis.
    Saxne T; Heinegård D
    J Rheumatol Suppl; 1995 Feb; 43():71-4. PubMed ID: 7752144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the role of molecular markers to monitor disease, intervention, and cartilage breakdown in osteoarthritis.
    Lohmander LS; Felson DT
    J Rheumatol; 1997 Apr; 24(4):782-5. PubMed ID: 9101518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of moving training on histology and biomarkers levels of articular cartilage.
    Qi C; Changlin H
    J Surg Res; 2006 Oct; 135(2):352-63. PubMed ID: 16904690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Absolute risk for fracture and WHO guideline. Biological markers for osteoarthritis (OA)].
    Date H; Yamada H; Kanaji A; Tajima K; Hayakawa K; Maehara K; Miyazaki K; Masuda H;
    Clin Calcium; 2007 Jul; 17(7):1071-9. PubMed ID: 17607075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pessimistic view of serologic markers for diagnosis and management of osteoarthritis. Biochemical, immunologic and clinicopathologic barriers.
    Brandt KD
    J Rheumatol Suppl; 1989 Aug; 18():39-42. PubMed ID: 2681766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of shear stress on articular chondrocyte metabolism.
    Lane Smith R; Trindade MC; Ikenoue T; Mohtai M; Das P; Carter DR; Goodman SB; Schurman DJ
    Biorheology; 2000; 37(1-2):95-107. PubMed ID: 10912182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metalloproteinases and tumor necrosis factor-alpha activities in synovial fluids of horses: correlation with articular cartilage alterations.
    Jouglin M; Robert C; Valette JP; Gavard F; Quintin-Colonna F; Denoix JM
    Vet Res; 2000; 31(5):507-15. PubMed ID: 11050746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological markers in osteoarthritis.
    Rousseau JC; Delmas PD
    Nat Clin Pract Rheumatol; 2007 Jun; 3(6):346-56. PubMed ID: 17538566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
    Lohmander LS; Ionescu M; Jugessur H; Poole AR
    Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum markers of systemic disease processes in osteoarthritis.
    Thonar EJ; Masuda K; Lenz ME; Hauselmann HJ; Kuettner KE; Manicourt DH
    J Rheumatol Suppl; 1995 Feb; 43():68-70. PubMed ID: 7752142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated intraarticular injections of triamcinolone acetonide alter cartilage matrix metabolism measured by biomarkers in synovial fluid.
    Céleste C; Ionescu M; Robin Poole A; Laverty S
    J Orthop Res; 2005 May; 23(3):602-10. PubMed ID: 15885481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High levels of aggrecan aggregate components are present in synovial fluids from human knee joints with chronic injury or osteoarthrosis.
    Ratcliffe A; Grelsamer RP; Kiernan H; Saed-Nejad F; Visco D
    Acta Orthop Scand Suppl; 1995 Oct; 266():111-5. PubMed ID: 8553838
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biological markers of the destruction of articular cartilage: current aspects].
    Vignon E; Conrozier T; Hellio MP; Piperno M; Mathieu P; Richard M
    Rev Prat; 1997 Nov; 47(17 Suppl):S11-5. PubMed ID: 9453176
    [No Abstract]   [Full Text] [Related]  

  • 18. Macromolecular markers in joint disease.
    Heinegård D; Saxne T
    J Rheumatol Suppl; 1991 Feb; 27():27-9. PubMed ID: 2027121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of cartilage turnover. Part 1: Markers of collagen degradation and synthesis.
    Garvican ER; Vaughan-Thomas A; Innes JF; Clegg PD
    Vet J; 2010 Jul; 185(1):36-42. PubMed ID: 20488735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.